1. King, M. T. (2011). A point of minimal important difference (MID): a critique of terminology and methods, Expert Review of Pharmacoeconomics & Outcomes Research 11, 171-184.
2. Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life, Journal of Clinical Epidemiology 56, 395-407.
3. Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of Health-Status - Ascertaining the Minimal Clinically Important Difference, Controlled Clinical Trials 10, 407-415.
4. Sloan, J. A., Cella, D., Frost, M., Guyatt, G. H., Sprangers, M., & Symonds, T. (2002). Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms, Mayo Clinic Proceedings 77, 367-370.
5. Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores, Journal of Clinical Oncology 16, 139-144.
6. Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening, Quality of Life Research 11, 207-221.
7. Ousmen, A., Touraine, C., Deliu, N., Cottone, F., Bonnetain, F., Efficace, F. et al. (2018). Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review, Health and Quality of Life Outcomes 16, 228-doi: 10.1186/s12955-018-1055-z.
8. Ringash, J., O'Sullivan, B., Bezjak, A., & Redelmeier, D. A. (2007). Interpreting clinically significant changes in patient-reported outcomes, Cancer 110, 196-202.
9. Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C. et al. (2006). The clinical significance of quality of life assessments in oncology: a summary for clinicians, Supportive Care in Cancer 14, 988-998.
10. Lemieux, J., Beaton, D. E., Hogg-Johnson, S., Bordeleau, L. J., & Goodwin, P. J. (2007). Three methods for minimally important difference: no relationship was found with the net proportion of patients improving, Journal of Clinical Epidemiology 60, 448-455.
11. Cocks, K., King, M. T., Velikova, G., de Castro, G., St James, M. M., Fayers, P. M. et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30, European Journal of Cancer 48, 1713-1721.
12. Musoro, Z. J., Hamel, J. F., Ediebah, D. E., Cocks, K., King, M. T., Groenvold, M. et al. (2018). Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol, Bmj Open 8, e019117-doi: 10.1136/bmjopen-2017-019117.
13. Kvam, A. K., Fayers, P., & Wisloff, F. (2010). What changes in health-related quality of life matter to multiple myeloma patients? A prospective study, European Journal of Haematology 84, 345-353.
14. Bedard, G., Zeng, L., Zhang, L. Y., Lauzon, N., Holden, L., Tsao, M. et al. (2016). Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients, Asia-Pacific Journal of Clinical Oncology 12, E38-E46.
15. Raman, S., Ding, K. Y., Chow, E., Meyer, R. M., van der Linden, Y. M., Roos, D. et al. (2018). Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases, Quality of Life Research 27, 1089-1098.
16. Sully, K., Trigg, A., Bonner, N., Moreno-Koehler, A., Trennery, C., Shah, N. et al. (2019). Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients, European Journal of Haematology 103, 500-509.
17. Reni, M., Braverman, J., Hendifar, A., Li, C. P., Mercade, T. M., Oh, D. Y. et al. (2019). Evaluation of minimal important difference (MID) for the European organisation for research and treatment of cancer (EORTC) pancreatic cancer module (PAN26) in patients with surgically resected pancreatic adenocarcinoma, Annals of Oncology 30, 262.
18. Singer, S., Amdal, C. D., Hammerlid, E., Tomaszewska, I. M., Silva, J. C., Mehanna, H. et al. (2019). International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV, Head and Neck 41, 1725-1737.
19. Singer, S., Araújo, C., Arraras, J., Baumann, I., Boehm, A., Herlofson, B. B. et al. (2015). Measuring Quality of Life in Head and Neck Cancer Patients - Update of the EORTC QLQ-H&N Module, Phase III, Head and Neck 37, 1358-1367.
20. Singer, S., Arraras, J., Baumann, I., Boehm, A., Chie, W. C., Galalae, R. et al. (2013). Quality of life in head and neck cancer patients receiving multimodal or targeted therapy - Update of the EORTC QLQ-H&N35, Phase I, Head and Neck 35, 1331-1338.
21. Singer, S., Arraras, J., Chie, W. C., Fisher, S., Galalae, R., Hammerlid, E. et al. (2013). Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35. A methodological review, Quality of Life Research 22, 1927-1941.
22. Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J. F., Biorklund, A. et al. (2001). A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part II: Longitudinal Data, Laryngoscope 111, 1440-1452.
23. Nordgren, M., Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., & Jannert, M. (2008). Quality of life in oral carcinoma: a 5-year prospective study, Head & Neck 30, 461-470.
24. Abendstein, H., Nordgren, M., Boysen, M., Jannert, M., Silander, E. M., Ahlner-Elmqvist, M. et al. (2005). Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study, Laryngoscope 115, 2183-2192.
25. Roick, J., Danker, H., Dietz, A., Papsdorf, K., & Singer, S. (2020). Predictors of changes in quality of life in head and neck cancer patients - a prospective study over a six-month period, European Archives of Oto-Rhino-Laryngology 277, 559-567.
26. Taylor, K., & Singer, S. (2019). Long-term quality of life in head and neck cancer patients. A systematic review, Der Onkologe 25, 125-131.
27. Singer, S., Danker, H., Guntinas-Lichius, O., Oeken, J., Pabst, F., Schock, J. et al. (2014). Quality of life before and after total laryngectomy – Results of a multi-centre prospective cohort study, Head and Neck 36, 359-368.
28. Aaronson, N., Ahmedzai, S., Bergmann, B., Bullinger, M., Cull, A., Duez, N. J. et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, J Nat Cancer Institute 85, 365-376.
29. Fayers, P. M., & Machin, D. (2007). Quality of Life, 2 edn., Wiley, Chichester.
30. Devji, T., Carrasco-Labra, A., Qasim, A., Phillips, M., Johnston, B. C., Devasenapathy, N. et al. (2020). Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study, British Medical Journal 369, Article Number: m1714.
31. Youden, W. J. (1950). Index for rating diagnostic tests, Cancer 3, 32-35.
32. Terluin, B., Eekhout, I., Terwee, C., & De Vet, H. C. W. (2015). Minimal important chnge (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis, Journal of Clinical Epidemiology 68, 1388-1396.
33. Crary, M. A., Mann, G. D. C., & Groher, M. E. (2005). Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients, Archives of Physical Medicine and Rehabilitation 86, 1516-1520.
34. Rosenbek, J. C., Robbins, J. A., Roecker, E. B., Coyle, J. L., & Wood, J. L. (1996). A penetration aspiration scale, Dysphagia 11, 93-98.
35. Hutcheson, K. A., Barrow, M. P., Barringer, D. A., Knott, J. K., Lin, H. Y., Weber, R. S. et al. (2017). Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale Development and Validation, Cancer 123, 62-70.
36. Chen, A. Y., Frankowski, R., Bishop-Leone, J., Hebert, T., Leyk, S., Lewin, J. et al. (2001). The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer - The M. D. Anderson dysphagia inventory, Archives of Otolaryngology-Head & Neck Surgery 127, 870-876.
37. Carnaby, G. D., & Crary, M. A. (2014). Development and validation of a cancer-specific swallowing assessment tool: MASA-C, Supportive Care in Cancer 22, 595-602.
38. Cocks, K., Velikova, G., King, M. T., Fayers, P. M., & Brown, J. M. (2014). Can individual patients assess differences in quality of life between groups of patients?, European Journal of Cancer Care 23, 228-238.
39. Bindewald, J., Herrmann, E., Dietz, A., Wulke, C., Meister, E. F., Wollbruck, D. et al. (2007). [Quality of life and voice intelligibility in laryngeal cancer patients--relevance of the "satisfaction paradox"]. [German], Laryngo- Rhino- Otologie 86, 426-430.
40. Schwartz, C. E., Bode, R., Repucci, N., Becker, J., Sprangers, M. A., & Fayers, P. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift, Quality of Life Research 15, 1533-1550.
41. Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: a theoretical model, Social Science and Medicine 48, 1507-1515.
42. Nordgren, M., Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., & Jannert, M. (2008). Quality of life in oral carcinoma: a 5-year prospective study, Head & Neck 30, 461-470.
43. Giesinger, J. M., Aaronson, N. K., Arraras, J. I., Efficace, F., Groenvold, M., Kieffer, J. M. et al. (2018). A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important, Psycho-Oncology 27, 548-555.
44. Fahsl, S., Keszte, J., Boehm, A., Vogel, H.-J., Völkel, W., Meister, E. F. et al. (2012). Clinical relevance of quality of life data in laryngectomized patients, Laryngoscope 122, 1532-1538.